Antiviral drugs

Anti-MAVS mitochondrial antiviral signaling protein, 100ul U

Anti-MAVS mitochondrial antiviral signaling protein, 100ul U

Anti-MAVS mitochondrial antiviral signaling protein, 25ul UN

Anti-MAVS mitochondrial antiviral signaling protein, 25ul UN

Anti-MBD6 methyl-CpG binding domain protein 6, 100ul UN 1687

ANTI-MBNL1 CLONE 1H11 ZOOMAB« RABBIT MONOCLONAL

ANTI-MBNL1 CLONE 1H11 ZOOMAB« RABBIT MONOCLONAL

Immunodeficiency virus type I enhancer binding protein/cirhin interaction protein/Myc promoter-binding protein-1 (HIVEP1, CIRIP, MBP-1, ZNF40, PRDII-BF1) is a transcription factor involved in the activation of HIV-1 gene expression and the

General description MED18 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).

General description Mediator of RNA polymerase II transcription subunit 28 (UniProt Q9H204: also known as Endothelial-derived protein 1, Magicin, Mediator complex subunit 28, Merlin and Grb2-interacting cytoskeletal protein, Tumor angiogenesis

Immunogen Synthetic peptide directed towards the N terminal region of human MEFV Biochem/physiol Actions MEFV was identified as the gene that when mutated causes Mediterranean fever, a hereditary periodic fever syndrome. MEFV is expressed in

Anti-MEFV MEFV, pyrin innate immunity regulator, 100ul UN 16